MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the global growth consulting company Frost & Sullivan has named Noven its 2006 Transdermal Drug Delivery Company of the Year, citing the competitive advantages of Noven’s patented DOT Matrix™ transdermal technology, the continued success of its commercialized transdermal systems, and its continuing efforts to enter new markets with innovative products.
